Pee Cee Cosma

  • Market Cap: Micro Cap
  • Industry: FMCG
  • ISIN: INE417E01010
  • NSEID:
  • BSEID: 524136
INR
295.65
-6.4 (-2.12%)
BSENSE

Jun 25, 03:30 PM

BSE+NSE Vol: 141

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

141 (-84.80%) Volume

Shareholding (Mar 2026)

FII

0.00%

Held by 0 FIIs

DII

0.78%

Held by 0 DIIs

Promoter

72.58%

Why is Pee Cee Cosma Sope Ltd falling/rising?

28-Jun-2026

As of 27-Jun, Pee Cee Cosma Sope Ltd's stock price is at 295.65, reflecting a significant decline of 37.36% over the past year, underperforming the market. Despite some positive financial results, weak long-term fundamentals and decreased investor participation indicate continued negative sentiment.

As of 27-Jun, Pee Cee Cosma Sope Ltd's stock price is falling, currently at 295.65, which reflects a decrease of 6.4 or 2.12%. The stock has underperformed the market significantly over various periods, with a year-to-date decline of 22.20% compared to a 9.53% drop in the Sensex. Over the past year, the stock has experienced a substantial decline of 37.36%, while the broader market has only fallen by 6.83%. <BR><BR>Today's performance indicates a trend reversal, as the stock has fallen after two consecutive days of gains. Additionally, the stock's performance today has underperformed its sector by 0.91%. The delivery volume has also seen a significant drop, falling by 85.22% against the 5-day average, indicating a decrease in investor participation. <BR><BR>While there were positive results reported on March 26, including a notable increase in profit before tax and net sales, the overall long-term fundamentals appear weak, with a 12.60% compound annual growth rate in operating profits over the last five years. This weak performance, combined with the stock trading at a discount compared to its peers, suggests that investor sentiment remains negative, contributing to the stock's decline.

View full answer

What does Pee Cee Cosma do?

11-Jun-2026

Pee Cee Cosma Sope Ltd manufactures laundry soap and detergent powder, operating as a micro-cap company with a market cap of INR 80 Cr. As of March 2026, it reported net sales of 43 Cr and a net profit of 1 Cr.

Overview:<BR>Pee Cee Cosma Sope Ltd is engaged in the manufacturing of laundry soap, detergent powder, and cake, operating within the FMCG industry and classified as a micro-cap company.<BR><BR>History:<BR>The company was incorporated in November 1986 by a private Indian party and became a public limited company in 1989. The latest quarterly results reported net sales and net profit for March 2026.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 43 Cr (Quarterly Results - Mar 2026) <BR>Most recent Net Profit: 1 Cr (Quarterly Results - Mar 2026) <BR>Market-cap value: INR 80 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 9.00 <BR>Industry P/E: 45 <BR>Dividend Yield: 1.00% <BR>Debt Equity: -0.38 <BR>Return on Equity: 14.88% <BR>Price to Book: 1.41 <BR><BR>Contact Details:<BR>Address: Padam Deep 5th Floor, G-10/8 Sanjay Place Agra Uttar Pradesh : 282002 <BR>Tel: 91-0562-2527332 <BR>Email: pccosmalisting@doctorsoap.com <BR>Website: http://www.peeceecosma.com

View full answer

How big is Pee Cee Cosma?

11-Jun-2026

As of 10th June, Pee Cee Cosma Sope Ltd has a market capitalization of 80.00 Cr, with recent net sales of 157.97 Cr and a net profit of 8.35 Cr. The balance sheet for March 2025 shows shareholder's funds of 48.57 Cr and total assets of 57.39 Cr.

As of 10th June, Pee Cee Cosma Sope Ltd has a market capitalization of 80.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, the company reported Net Sales of 157.97 Cr and a Net Profit of 8.35 Cr.<BR><BR>The latest annual period for the balance sheet is March 2025, showing Shareholder's Funds of 48.57 Cr and Total Assets of 57.39 Cr.

View full answer

Who are in the management team of Pee Cee Cosma?

11-Jun-2026

The management team of Pee Cee Cosma includes Mayank Jain (Chairman & Wholetime Director), Ankur Jain (Managing Director), Ankit Jain (Whole-time Director), Nidhi Agarwal (Company Secretary), and four Independent Directors: Nemi Chandra Jain, Anil Gupta, Babita Agarwal, and K Agarwal. This team combines leadership with independent oversight.

The management team of Pee Cee Cosma includes the following individuals:<BR><BR>1. **Mayank Jain** - Chairman & Wholetime Director<BR>2. **Ankur Jain** - Managing Director<BR>3. **Ankit Jain** - Whole-time Director<BR>4. **Nidhi Agarwal** - Company Secretary & Compliance Officer<BR>5. **Nemi Chandra Jain** - Independent Director<BR>6. **Anil Gupta** - Independent Director<BR>7. **Babita Agarwal** - Independent Director<BR>8. **K Agarwal** - Independent Director<BR><BR>This team brings a mix of leadership and independent oversight to the company.

View full answer

Who are the peers of the Pee Cee Cosma?

11-Jun-2026

Pee Cee Cosma's peers include Galaxy Supermark, Kovil. Lak. Rol., Shri Vasuprada, NHC Foods, Choksi Asia, Team24 Consumer, Terai Tea Co, and Simran Farms. NHC Foods shows the highest growth and return, while Galaxy Supermark has the lowest performance metrics.

Peers: The peers of Pee Cee Cosma are Galaxy Supermark, Kovil. Lak. Rol., Shri Vasuprada, NHC Foods, Choksi Asia, Team24 Consumer, Terai Tea Co, and Simran Farms.<BR><BR>Quality Snapshot: Good management risk is observed at Kovil. Lak. Rol. and Pee Cee Cosma, while Below Average management risk is found at Galaxy Supermark, Shri Vasuprada, NHC Foods, Choksi Asia, Team24 Consumer, Terai Tea Co, and Simran Farms. Below Average growth is noted at Galaxy Supermark, Kovil. Lak. Rol., Shri Vasuprada, and the rest, while Excellent growth is observed at NHC Foods, and Good growth is seen at Choksi Asia. Pee Cee Cosma has Excellent capital structure, while Below Average capital structure is found at Galaxy Supermark, Kovil. Lak. Rol., Shri Vasuprada, Team24 Consumer, Terai Tea Co, and Simran Farms, with Average capital structure at NHC Foods and Good capital structure at Choksi Asia.<BR><BR>Return Snapshot: NHC Foods has the highest 1-year return at 30.85%, while Galaxy Supermark has the lowest at -52.23%. Pee Cee Cosma's 1-year return of -36.10% is better than Galaxy Supermark's but worse than NHC Foods'. Additionally, the six-month return is negative for Galaxy Supermark, Kovil. Lak. Rol., Shri Vasuprada, Team24 Consumer, Terai Tea Co, and Simran Farms.

View full answer

Should I buy, sell or hold Pee Cee Cosma Sope Ltd?

31-May-2026

When is the next results date for Pee Cee Cosma Sope Ltd?

21-May-2026

The next results date for Pee Cee Cosma Sope Ltd is 29 May 2026.

The next results date for Pee Cee Cosma Sope Ltd is scheduled for 29 May 2026.

View full answer

Are Pee Cee Cosma Sope Ltd latest results good or bad?

07-Feb-2026

Pee Cee Cosma Sope Ltd's latest results are concerning, with a 50.17% decline in net profit and a contraction in operating margin to 5.73%. The stock has also dropped 45.07% over the past year, indicating significant challenges for the company.

The latest results for Pee Cee Cosma Sope Ltd indicate a challenging situation for the company. In Q2 FY26, the company reported a net profit of ₹1.45 crore, which represents a significant decline of 50.17% quarter-on-quarter and 45.49% year-on-year. This sharp drop in profitability is concerning, especially given that the operating margin also contracted to 5.73%, down from 8.74% in the previous quarter.<BR><BR>While net sales showed a slight year-on-year increase of 5.49%, they fell by 18.30% compared to the previous quarter, indicating potential issues with demand or operational efficiency. The overall financial performance reflects significant margin compression and operational challenges that the management will need to address urgently.<BR><BR>Additionally, the stock has been under severe pressure, trading at ₹334.90, down 45.07% over the past year, and it is currently below all key moving averages. This bearish sentiment in the market further highlights investor concerns regarding the company's future performance.<BR><BR>In summary, the latest results can be characterized as bad, primarily due to the substantial declines in both net profit and operating margins, alongside a significant drop in stock price.

View full answer

Is Pee Cee Cosma overvalued or undervalued?

05-Dec-2025

As of December 4, 2025, Pee Cee Cosma is fairly valued with a PE ratio of 12.79 and an EV to EBITDA of 8.03, especially when compared to overvalued peers like Hindustan Unilever and Nestle India, despite its year-to-date stock performance lagging at -34.46% against the Sensex's 9.12%.

As of 4 December 2025, the valuation grade for Pee Cee Cosma has moved from attractive to fair, indicating a shift in market perception. The company is currently fairly valued based on its financial metrics. Key ratios include a PE ratio of 12.79, an EV to EBITDA of 8.03, and a ROE of 15.16%. <BR><BR>In comparison to its peers, Pee Cee Cosma's valuation stands out against Hindustan Unilever, which has a PE ratio of 54.69, and Nestle India, with a PE of 80. This suggests that while Pee Cee Cosma is fairly valued, its peers are significantly overvalued. Additionally, the company's recent stock performance has lagged behind the Sensex, with a year-to-date return of -34.46% compared to the Sensex's 9.12%, reinforcing the notion of a fair valuation amidst a challenging market environment.

View full answer

How has been the historical performance of Pee Cee Cosma?

13-Nov-2025

Pee Cee Cosma's historical performance shows mixed results, with net sales increasing to 144.34 crore but a decline in operating profit and profit after tax, reflecting challenges in profitability despite growth in sales and total assets. Cash flow from operations also decreased, indicating further financial difficulties.

Answer:<BR>The historical performance of Pee Cee Cosma shows a mixed trend in financial metrics over the past year.<BR><BR>Breakdown:<BR>In the fiscal year ending March 2025, Pee Cee Cosma reported net sales of 144.34 crore, an increase from 133.64 crore in March 2024. However, total operating income remained the same as net sales, with no other operating income reported. The raw material cost rose significantly to 104.84 crore from 90.30 crore, contributing to a total expenditure of 131.30 crore, up from 118.29 crore the previous year. Consequently, the operating profit (PBDIT) decreased to 14.81 crore from 15.95 crore, reflecting a decline in the operating profit margin from 11.49% to 9.03%. Profit before tax also fell to 12.94 crore from 14.05 crore, leading to a profit after tax of 9.64 crore, down from 10.44 crore, resulting in a PAT margin decrease from 7.81% to 6.68%. On the balance sheet, total assets increased to 57.39 crore from 47.84 crore, while total liabilities also rose to 57.39 crore, up from 47.84 crore. The book value per share improved to 183.54 from 152.23. Cash flow from operating activities decreased to 7.00 crore from 10.00 crore, and the net cash inflow/outflow remained at 0.00 crore for the last two years. Overall, while sales and total assets showed growth, profitability metrics and cash flow from operations indicated challenges for the company.

View full answer

How has been the historical performance of Pee Cee Cosma?

12-Nov-2025

Pee Cee Cosma's historical performance shows increased net sales and total assets, but declines in operating profit, profit before tax, and cash flow from operations over the past year. Overall, while sales growth is evident, profitability has decreased.

Answer:<BR>The historical performance of Pee Cee Cosma shows a mixed trend in its financial metrics over the past year.<BR><BR>Breakdown:<BR>In the fiscal year ending March 2025, Pee Cee Cosma reported net sales of 144.34 Cr, an increase from 133.64 Cr in March 2024. The total operating income also rose to 144.34 Cr from 133.64 Cr, while total expenditure increased to 131.30 Cr from 118.29 Cr. The operating profit (PBDIT) excluding other income decreased to 13.04 Cr from 15.35 Cr, leading to an overall operating profit of 14.81 Cr, down from 15.95 Cr. Profit before tax fell to 12.94 Cr from 14.05 Cr, and profit after tax decreased to 9.64 Cr from 10.44 Cr. The earnings per share (EPS) also declined to 36.38 from 39.4. On the balance sheet, total assets increased to 57.39 Cr from 47.84 Cr, with total liabilities rising to 57.39 Cr from 47.84 Cr. The book value per share adjusted rose to 183.54 from 152.23. Cash flow from operating activities decreased to 7.00 Cr from 10.00 Cr, while cash flow from investing activities remained stable at -5.00 Cr. Overall, the financial performance indicates growth in sales and assets but a decline in profitability and cash flow from operations.

View full answer

Who are the top shareholders of the Pee Cee Cosma?

17-Jul-2025

The top shareholder of Pee Cee Cosma is Ankit Jain, holding 9.44%, with individual investors collectively owning 20.67%. There are no pledged promoter holdings, mutual funds, or foreign institutional investors involved.

The top shareholders of Pee Cee Cosma primarily consist of promoters, with Ankit Jain being the individual with the highest holding at 9.44%. There are no pledged promoter holdings, and the company does not have any mutual funds or foreign institutional investors (FIIs) holding shares. Additionally, individual investors collectively hold 20.67% of the shares. There are no significant public shareholders listed.

View full answer

What is the technical trend for Pee Cee Cosma?

09-Jun-2025

As of May 23, 2025, Pee Cee Cosma's trend has shifted to bearish with moderate strength, driven by bearish indicators like the MACD and moving averages, despite some bullish momentum in the RSI.

As of 23 May 2025, the technical trend for Pee Cee Cosma has changed from mildly bearish to bearish. The current stance is bearish with moderate strength. Key indicators driving this include a bearish MACD on the weekly chart, bearish moving averages on the daily chart, and a bearish KST on the weekly chart. The Bollinger Bands also indicate a mildly bearish trend on both weekly and monthly time frames. The RSI shows bullish momentum on the weekly, but this is overshadowed by the overall bearish signals. The Dow Theory indicates no trend on both weekly and monthly time frames, suggesting a lack of directional conviction.

View full answer

Has Pee Cee Cosma declared dividend?

06-Jun-2025

Yes, Pee Cee Cosma Sope Ltd has declared a 30% dividend, amounting to ₹3 per share, with an ex-date of September 20, 2024. While recent returns show volatility, the company has demonstrated strong long-term growth, particularly in price appreciation.

Pee Cee Cosma Sope Ltd has declared a 30% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 30%<BR>- Amount per share: 3<BR>- Ex-date: 20 Sep 24<BR><BR>Dividend Yield: 1.03%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was -26.73%, with a dividend return of 0%, resulting in a total return of -26.73%.<BR><BR>Over the past year, the price return was 18.52%, the dividend return was 0.69%, leading to a total return of 19.21%.<BR><BR>In the 2-year period, the price return was 134.15%, the dividend return was 2.48%, culminating in a total return of 136.63%.<BR><BR>For the 3-year period, the price return was 342.05%, with a dividend return of 5.66%, resulting in a total return of 347.71%.<BR><BR>In the last 4 years, the price return was 213.67%, the dividend return was 5.68%, leading to a total return of 219.35%.<BR><BR>Over the past 5 years, the price return was 503.07%, with a dividend return of 11.79%, resulting in a total return of 514.86%.<BR><BR>Overall, Pee Cee Cosma has declared a significant dividend, and while the recent returns over shorter periods show volatility, the longer-term returns indicate strong growth, particularly in price appreciation.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Weak Long Term Fundamental Strength with a 12.60% CAGR growth in Operating Profits over the last 5 years

 
2

Underperformed the market in the last 1 year

stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

FMCG

stock-summary
Market cap

INR 81 Cr (Micro Cap)

stock-summary
P/E

10.00

stock-summary
Industry P/E

46

stock-summary
Dividend Yield

0.99%

stock-summary
Debt Equity

-0.38

stock-summary
Return on Equity

14.88%

stock-summary
Price to Book

1.43

Revenue and Profits:
Net Sales:
43 Cr
(Quarterly Results - Mar 2026)
Net Profit:
1 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.99%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-4.98%
0%
-4.98%
6 Months
-19.01%
0%
-19.01%
1 Year
-37.36%
0.61%
-36.75%
2 Years
-33.8%
1.07%
-32.73%
3 Years
57.68%
3.66%
61.34%
4 Years
176.7%
7.22%
183.92%
5 Years
75.41%
6.87%
82.28%

Latest dividend: 2.959683794466403 per share ex-dividend date: Sep-19-2025

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

Announcements stock-summary

Closure of Trading Window

22-Jun-2026 | Source : BSE

CLOSURE OF TRADING WINDOW FROM 1ST JULY 2026 TILL COMPLETION OF 48 HOURS FROM THE ANNOUNCEMENT OF UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 30TH JUNE 2026 TO STOCK EXCHANGE

Announcement under Regulation 30 (LODR)-Newspaper Publication

02-Jun-2026 | Source : BSE

PUBLICATION OF AUDITED RESULTS IN NEWSPAPER

Board Meeting Outcome for Approval Of Audited Resuts(Standalone And Consolidated). Recommendation Of 30% Dividend Subject To Shareholders Approval Reappointment Of Internal And Cost Auditors

29-May-2026 | Source : BSE

approval of audited resuts(standalone and consolidated). recommendation of 30% dividend subject to shareholders approval reappointment of internal and cost auditors

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Pee Cee Cosma Sope Ltd has declared 30% dividend, ex-date: 19 Sep 25

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
13.92%
EBIT Growth (5y)
12.60%
EBIT to Interest (avg)
11.20
Debt to EBITDA (avg)
1.11
Net Debt to Equity (avg)
-0.38
Sales to Capital Employed (avg)
2.75
Tax Ratio
25.63%
Dividend Payout Ratio
8.26%
Pledged Shares
0
Institutional Holding
0.78%
ROCE (avg)
21.35%
ROE (avg)
17.32%

Valuation key factors

Factor
Value
P/E Ratio
10
Industry P/E
46
Price to Book Value
1.42
EV to EBIT
5.30
EV to EBITDA
4.61
EV to Capital Employed
1.68
EV to Sales
0.37
PEG Ratio
NA
Dividend Yield
0.99%
ROCE (Latest)
31.70%
ROE (Latest)
14.88%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Ankit Jain (9.44%)

Highest Public shareholder

None

Individual Investors Holdings

21.05%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 19.81% vs 18.50% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 48.44% vs -76.38% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "43.36",
          "val2": "36.19",
          "chgp": "19.81%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3.20",
          "val2": "1.46",
          "chgp": "119.18%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.03",
          "val2": "0.07",
          "chgp": "-57.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.95",
          "val2": "0.64",
          "chgp": "48.44%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "7.38%",
          "val2": "4.03%",
          "chgp": "3.35%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is 2.34% vs 2.14% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is -25.96% vs 21.66% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "72.45",
          "val2": "70.79",
          "chgp": "2.34%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "5.46",
          "val2": "7.31",
          "chgp": "-25.31%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.03",
          "val2": "0.07",
          "chgp": "-57.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "4.45",
          "val2": "6.01",
          "chgp": "-25.96%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "7.54%",
          "val2": "10.33%",
          "chgp": "-2.79%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is 8.92% vs 1.93% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is -16.20% vs 15.78% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "114.47",
          "val2": "105.10",
          "chgp": "8.92%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "9.58",
          "val2": "11.53",
          "chgp": "-16.91%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.05",
          "val2": "0.16",
          "chgp": "-68.75%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "7.50",
          "val2": "8.95",
          "chgp": "-16.20%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "8.37%",
          "val2": "10.97%",
          "chgp": "-2.60%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 9.44% vs 8.01% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is -13.59% vs -7.66% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "157.97",
          "val2": "144.34",
          "chgp": "9.44%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "12.66",
          "val2": "13.04",
          "chgp": "-2.91%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.09",
          "val2": "0.22",
          "chgp": "-59.09%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "8.33",
          "val2": "9.64",
          "chgp": "-13.59%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "8.01%",
          "val2": "9.03%",
          "chgp": "-1.02%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoYstock-summary

Mar'26
Mar'25
Change(%)
Net Sales
43.36
36.19
19.81%
Operating Profit (PBDIT) excl Other Income
3.20
1.46
119.18%
Interest
0.03
0.07
-57.14%
Exceptional Items
0.00
0.00
Consolidate Net Profit
0.95
0.64
48.44%
Operating Profit Margin (Excl OI)
7.38%
4.03%
3.35%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in quarter ended Mar 2026 is 19.81% vs 18.50% in Mar 2025

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is 48.44% vs -76.38% in Mar 2025

Half Yearly Results Snapshot (Standalone) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
72.45
70.79
2.34%
Operating Profit (PBDIT) excl Other Income
5.46
7.31
-25.31%
Interest
0.03
0.07
-57.14%
Exceptional Items
0.00
0.00
Standalone Net Profit
4.45
6.01
-25.96%
Operating Profit Margin (Excl OI)
7.54%
10.33%
-2.79%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is 2.34% vs 2.14% in Sep 2024

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2025 is -25.96% vs 21.66% in Sep 2024

Nine Monthly Results Snapshot (Standalone) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
114.47
105.10
8.92%
Operating Profit (PBDIT) excl Other Income
9.58
11.53
-16.91%
Interest
0.05
0.16
-68.75%
Exceptional Items
0.00
0.00
Standalone Net Profit
7.50
8.95
-16.20%
Operating Profit Margin (Excl OI)
8.37%
10.97%
-2.60%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2025 is 8.92% vs 1.93% in Dec 2024

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2025 is -16.20% vs 15.78% in Dec 2024

Annual Results Snapshot (Consolidated) - Mar'26stock-summary

Mar'26
Mar'25
Change(%)
Net Sales
157.97
144.34
9.44%
Operating Profit (PBDIT) excl Other Income
12.66
13.04
-2.91%
Interest
0.09
0.22
-59.09%
Exceptional Items
0.00
0.00
Consolidate Net Profit
8.33
9.64
-13.59%
Operating Profit Margin (Excl OI)
8.01%
9.03%
-1.02%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2026 is 9.44% vs 8.01% in Mar 2025

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2026 is -13.59% vs -7.66% in Mar 2025

stock-summaryCompany CV
About Pee Cee Cosma Sope Ltd stock-summary
stock-summary
Pee Cee Cosma Sope Ltd
Micro Cap
FMCG
Pee Cee Cosma Sope Limited was incorporated in November, 1986 by a private Indian party. The Company is engaged in the business of Manufacturing of Laundry Soap, Detergent Powder and Cake operating in State of Uttar Pradesh, Rajasthan and Madhya Pradesh. Company became a public limited company in 1989 and its shares got listed on the Bombay Stock Exchange Ltd.
Company Coordinates stock-summary
Company Details
Padam Deep 5th Floor, G-10/8 Sanjay Place Agra Uttar Pradesh : 282002
stock-summary
Tel: 91-0562-2527332
stock-summary
pccosmalisting@doctorsoap.com
Registrar Details
Skyline Financial Services Pvt Ltd , D-153/A, 1st Floor, Okhla Industrial Area, Phase - I, New Delhi